JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sergeant, P.
Right arrow Articles by Meyns, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sergeant, P.
Right arrow Articles by Meyns, B.

J Thorac Cardiovasc Surg 1998;116:440-444
© 1998 Mosby, Inc.


Surgery for Adult Cardiovascular Disease

Is return of angina after coronary artery bypass grafting immutable, can it be delayed, and is it important?

P. Sergeant, MD, E. Blackstone, MD*, B. Meyns, MD

*Formerly Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Ala.; currently Cleveland Clinic Foundation, Cleveland, Ohio.

Read at the Seventy-seventh Annual Meeting of The American Association for Thoracic Surgery, Washington, D.C., May 4-7, 1997.

Received for publication May 12, 1997. Revisions requested July 19, 1997; revisions received April 17, 1998. Accepted for publication April 29, 1998. Address for reprints: Prof. Dr. Paul Sergeant, Cardiac Surgery Department, Gasthuisberg University Hospital, Herestraat 49, 3000 Leuven, Belgium.


    Abstract
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Appendix: Discussion
 Appendixes
 References
 
Background: Because survival after either an operation or angioplasty is similar across a wide spectrum of coronary patients, lasting symptom relief assumes high priority.
Objectives: The objectives of this observational clinical study were (1) to determine whether the return of angina is immutable; (2) to identify factors that might delay its return, and (3) to evaluate whether its return is predictive of subsequent adverse events.
Methods: The return of angina of any degree of severity and morbid events subsequent to its return were studied by multivariable time-related analyses in a consecutive series of 9600 patients who were undergoing primary isolated coronary bypass operations between 1971 and 1992.
Results: The freedom rate from return of angina was 94%, 82%, 61% and 38% at 1, 5, 10, and 15 years. Increased modest risk of early return of angina was associated with preoperative demographic, symptom, coronary and vascular disease variables but reduced by more extensive arterial grafting. The ever-increasing risk of late return of angina was associated with demographic, symptomatic, left ventricular function, and coronary disease variables and was related strongly to comorbidity but was weakly reduced by controllable surgical variables. After the return of angina, 10-year freedom rate from infarct and survival was 71% and 68% respectively.
Conclusions: (1) The risk of angina return increases relentlessly after operation, so it is likely immutable. (2) Delay of late angina return by use of arterial grafting is clinically trivial; control of noncardiac comorbidity may be more effective. (3) Fortunately, the return of angina after coronary artery bypass grafting has minimal impact on survival and is not predictive of imminent infarct. (J Thorac Cardiovasc Surg 1998;116:440-53)


    Introduction
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Appendix: Discussion
 Appendixes
 References
 
Cardiac surgeons have migrated toward the use in coronary artery operation of multiple arterial grafts, including both internal thoracic (mammary) and gastroepiploic and radial arteries, under the assumption that, because a single arterial graft to the left anterior descending artery (LAD) improves graft patency and late survival, multiple arterial grafts would amplify the effect. However, it has been difficult to demonstrate a survival benefit of multiple arterial grafts compared with a single one,Go 1 and a previous study failed to identify a late benefit of even a single arterial graft on return of ischemic symptoms.Go 2 Therefore we have studied the return of angina symptoms after coronary artery bypass grafting (CABG) in a larger patient population in which both single and multiple arterial grafting has been performed with follow-up to 20 years to determine (1) whether return of angina is immutable, (2) the factors, including grafting technique, that might delay its onset, and (3) whether its return is predictive of subsequent adverse events.


    Methods
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Appendix: Discussion
 Appendixes
 References
 
Patients
A consecutive series of 9600 patients underwent isolated first time CABG at the Gasthuisberg University Hospital of Leuven (Katholieke Universiteit Leuven) in Belgium from the start of CABG in 1971 until January 1992. Single coronary system disease was present in 11% of the patients, 2-system disease in 29% of the patients, and 3-system disease in 60% of the patients. The complete dataset has been described and characterized in detail in a previous publication.Go 1

Surgical technique
The number of conduits used was 1 (12%), 2 (42%), 3 (38%), 4 (7%), and 5 (1%). The number of distal anastomoses was 1 (9%), 2 (24%), 3 (31%), 4 (23%), 5 (10%), 6 (3%), 7 (1%), 8 (0.2%), 9 (0.02%), and 10 (0.01%).

The first internal thoracic artery (ITA) anastomosis was constructed in 1972, and 6074 patients had at least 1 in situ ITA anastomosis. The first bilateral in situ ITA graft (N = 1192) was used in 1973, and the first in situ sequential ITA graft (N = 711)Go 3 was performed in 1978. Bilateral ITA grafts were connected to 2 different coronary systems in 985 patients and to only 1 single system in 207 patients. Free ITA grafting was used in 122 patients.

Follow-up
A regular stream of follow-up reports from referring specialists updates the Katholieke Universiteit Leuven Coronary Surgery Database.Go 4 These reports are sent after each event, suspicion of event, or regular visit. In addition, a formal cross-sectional follow-up of known surviving patients was undertaken between January 1, 1993, and July 1, 1994.Go 1 The common closing date for outcomes information was set at 1 Jan 1993. The follow-up was complete for 99.9% of patients. The median follow-up for the survivors was 6.4 years. Table I gives the number of patients at risk by year after the operation (alive without having experienced the return of angina after CABG) and by number of in situ thoracic artery distal anastomoses.


View this table:
[in this window]
[in a new window]
 
Table I. No. of patients at risk by year after operation (alive without having had return of angina after CABG) and by number of in situ thoracic artery distal anastomoses
 
Once complete follow-up was obtained, the dataset was refined for intervals without any information, for timeframes around and or immediately after important clinical events, reangiographies, and cardiologic or cardiosurgical reinterventions. This cascade of letters was organized and monitored with a follow-up management information system.

Events
Return of angina
The object of the study was the event defined as return of angina of any degree of severity without death or infarct the same day. The intent was to identify patients with return of reversible ischemia in contrast to those experiencing an acute myocardial infarction. Patients not experiencing this event were censored at the common closing date, at the end of follow-up for those with incomplete follow-up, or at death, whichever occurred earliest. The diagnosis of angina was documented, at the discretion of the attending cardiologists, with cyclo-ergometric or radionucleide tests and coronary angiograms. When these were found to be normal and when the clinical history left doubt, the chest pain was not coded as return of angina.

Events after the return of angina
Events studied after the return of angina were death, myocardial infarction, and reintervention (cardiologic or cardiosurgical). The time interval from the return of angina (time-zero) to the occurrence of these events was analyzed.

Characterization of overall freedom from angina
Nonparametric estimates of overall non-risk–adjusted freedom rate from angina were obtained by the method of Kaplan and Meier.Go 5 A parametric method was used to resolve the number of hazard phases, to identify the form of the equation for each phase, and to estimate the parameters that characterized the distribution of times until first return of angina.Go 6

Depictions
In various figures, events are depicted by a symbol positioned along the horizontal axis at the time of the event and on the vertical axis according to the Kaplan-Meier life table estimate. They are enclosed at periodic intervals between confidence limits equivalent to 1 standard error. The numbers in parentheses represent the number of patients without the event and traced beyond that point. When parametric time-related depictions are shown, the solid line is the parametric estimate of freedom from the event enclosed within dashed 70% confidence limits equivalent to one standard error.

Multivariable analysis of return of angina
The general methods used to identify incremental risk factors for return of angina have been described previously for the event death,Go 1 including the variables and their organization for analysis and the exploratory analyses accompanying the multivariable analyses conducted in the parametric, multiphase hazard function domain.

In the directed stepwise entry of variables into the multivariable risk factor model, the P-value criterion for retention of variables in the final analysis was .05. Regression coefficients are presented ± 1 standard error.

Sequential analyses
To better understand the nature and influence of the risk factors, the multivariable analysis was conducted in a sequential fashion. First, only patient variables were entered, then procedure variables that were likely to be known or estimated at the time of decision-making were added, including the use and method of use of arterial grafts, and finally experience variables were entered. Variables from the isolated and preceding analyses were allowed to leave the model.

Nature and influence of risk factors
Nomograms representing the solution of the patient, procedure, and experience parametric equation for specific supplied values of each factor were used to explore the influence of risk factors. In general, each figure represents the prediction for a specific but typical hypothetical patient (Table II) whose profile was the median for patients who underwent an operation in the last year of entry into the study. Point estimates are enclosed within confidence limits equivalent to ± 1 SE. However, for statistical consistency, the solid lines for comparative difference in predicted percent freedom from angina are enclosed within dashed 90% confidence limits.


View this table:
[in this window]
[in a new window]
 
Table II. Patient-profile of the median patient used for the nomograms and patient-specific predictions
 

    Results
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Appendix: Discussion
 Appendixes
 References
 
Freedom from the return of angina after CABG
The non-risk adjusted 1-, 5-, 10-, and 15-year freedom rate from angina of any degree of severity, without infarct or death on the same day, was 94%, 82%, 61%, and 38%, respectively (Fig. 1, A). A 2-phase hazard function (Fig. 1, BGo) was identified. It consisted of a small early hazard phase that was slowly declining and a prominent late hazard phase that was continuing to rise relentlessly after approximately 2 years for the extent of the follow-up. The implication is that if a patient lives long enough, angina will return (is immutable).



View larger version (26K):
[in this window]
[in a new window]
 
Fig. 1. A, Parametric freedom from the return of angina, without death or infarct the same day, after primary isolated CABG (n = 9600). B, Hazard function for the return of angina, without death or infarct the same day, at any time after primary isolated CABG (n = 9600; instantaneous risk at every point in time after the operation).

 
In most instances, the return of angina was of mild severity (Table III).


View this table:
[in this window]
[in a new window]
 
Table III. The grade of angina at first return
 
Influence of choice of conduit on the return of angina after CABG
Risk unadjusted influence
Choice of arterial grafting compared with the choice of all vein grafts was associated with a lower risk–unadjusted prevalence of the return of angina after CABG (Fig. 2, A; P = .0001). Stratification by number of in situ ITA anastomoses identified no apparent additional benefit of multiple arterial grafting before risk adjustment (Fig. 2, BGo).



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2. A, Actuarial freedom from angina after primary CABG, by presence or absence of arterial grafting (combined or not with nonarterial grafting). B, Actuarial freedom from angina after primary CABG, by 1 or more than 1 in situ thoracic artery (IMA) distal anastomoses.

 
Risk adjusted influence
Choice of arterial grafting (by in situ ITA, free ITA, or gastroepiploic artery) reduced the prevalence of anginal events after CABG, both in early and late phases, after adjustment for demographic and patient variability (Table IV). Fig. 3 depicts this benefit for a median patient (Table II). For that patient, the benefit of arterial grafting is approximately 5% at 10 years. An additional benefit was an increasing ratio of arterial to total number of distal anastomoses, corresponding to an increase in the number of arterial grafts used (Fig. 4). The benefit of extensive arterial grafting disappeared by 24 months after CABG.


View this table:
[in this window]
[in a new window]
 
Table IV. Incremental risk factors and the P values, based on patient, procedure, and institutional variables, for the return of angina, without infarct or death the same day, after primary isolated CABG (see Appendix 2 for the selected variables, their coefficients, their standard error and their mathematic transformations)
 


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 3. Patient-specific prediction for a median patient (see Table II) validating the influence of the use of at least a single thoracic artery (IMA) anastomosis, preferably to the LAD, on the freedom from angina after CABG.

 


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 4. Patient-specific prediction for a median patient (see Table II) validating the influence of increasing the ratio of arterial to total anastomoses on the freedom from angina after CABG. A ratio of 0:3 means that no arterial distal anastomosis was constructed on a total of 3 distal anastomoses. A ratio of 3:3 means that 3 arterial distal anastomoses were constructed on a total of 3 distal anastomoses. Note that the horizontal time axis is limited to the first 12 months.

 
Influence of immutable and only possibly controllable risk factors
Immutable demographic variables of younger age and of female gender were associated with both increased early and late return of angina (Table IV). For a 55-year-old median-risk patient (Table II) compared with a 75-year-old median-risk patient, the difference in freedom rate from angina was 10%. For a median-risk woman compared with a median-risk man, this difference at 10 years was 13%.

Noncardiac nonvascular comorbidities were potent risk factors for late the return of angina after CABG. At 10 years after an operation, the freedom rate from angina was 35% for a median-risk patient (Table II) with insulin-treated diabetes, 44% for a patient with orally treated diabetes, and 45% for a hypertensive patient, compared with 51% for a patient without these comorbidities.

Events after the return of angina
Death
The parametric non-risk–adjusted 1-month and 10-year survival was 99% and 68% after the return of angina after CABG (Fig. 5, A). Uncorrected for patient and procedure variability, this survival rate was improved in the presence of an arterial graft (P = .0001). No additional reduction was identified by increasing the number of in situ thoracic artery anastomoses beyond a single one (P = .8) (Fig. 5, BGo). The more severe was the degree of angina at return, the worse was the subsequent survival rate (P = .0001). The 1-year survival rate was 80% when angina returned in the form of unstable angina and was 97% when the angina was mild (Fig. 5, CGo).



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 5. A, The actuarial and superimposed parametric survival function after the first return of angina after CABG (time 0, the moment of return of angina). B, Actuarial survival function (uncorrected for patient-variability) after the first return of angina after CABG (time 0, the moment of return of angina), stratified by patients with a single ITA (IMA) anastomosis versus patients with more than a single ITA anastomosis. C, The actuarial survival function (uncorrected for patient variability) after the first return of angina after CABG (time 0, the moment of return of angina) stratified by the grade of angina at first return of angina (see Table III).

 
Myocardial infarction
The parametric 1-month and 10-year non-risk–adjusted freedom rate from infarct (Fig. 6, A) after the return of angina after CABG was 97% and 71%. Uncorrected for patient variability, freedom from infarct was strongly less (P  = .0001) (Fig. 6, BGo) in the presence of an arterial graft. No additional reduction was identified in the presence of a larger number of in situ ITA anastomoses at the time of the original procedure (P = .17). The higher the severity grade of angina was at return, the more frequent (earlier) was the occurrence of an infarct (P = .0001) (Fig. 6, CGo).



View larger version (29K):
[in this window]
[in a new window]
 
Fig. 6. A, The actuarial and superimposed parametric freedom from infarct after the first return of angina after CABG (time 0, the moment of return of angina). B, The actuarial freedom from infarct (uncorrected for patient variability) after the first return of angina after CABG (time 0, the moment of return of angina), stratified by the presence of an arterial graft. C, The actuarial freedom rate from infarct (uncorrected for patient variability) after the first return of angina after CABG (time 0, the moment of return of angina) stratified by the grade of angina at the first return of angina (see Table III).

 
Reintervention
The parametric 1-month and 10-year non-risk–adjusted freedom rate from any cardiologic or cardiosurgical reintervention (Fig. 7) after return of angina after CABG was 96% and 59%.



View larger version (26K):
[in this window]
[in a new window]
 
Fig. 7. The actuarial and superimposed parametric freedom rates from any cardiologic or cardiosurgical reintervention (time 0, the moment of first return of angina).

 

    Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Appendix: Discussion
 Appendixes
 References
 
Limitations of the study
Intensity biases
The return of angina is a clinical event, based on careful interpretation of medical history, and therefore subject to possible bias. The first symptoms of the return of angina after CABG were most frequently of mild grade. Some may argue that the return or development of severe angina would have been a more discriminating end point. However, that presupposes a prognostic importance of the return of angina commensurate with its grade of severity. We chose not to take this approach but instead to study all grades of return of symptoms and to evaluate their prognostic importance.

Follow-up biases
Variable intensity of follow-up may have influenced the identification of the event. Medical care in Belgium is without financial consequences for the patient. It is possible that patients with considerable comorbidity have been subjected to more frequent follow-up. This is true for patients who are treated with dialysis or insulin. This difference in follow-up intensity could produce a biased association between these comorbidities and the event, certainly for mild grades of angina. A reverse bias is equally possible, where patients who have been symptom-free for years will visit their cardiologist at the first symptoms of chest pain, sometimes indistinguishable from muscular pains, even for experts.

Unavoidable under-reporting
Under-reporting of the event may have occurred from silent ischemia.

However, the combination of a continuous clinical event update system and periodic formal follow-up constitutes the potential power of this database for the analysis of a refined event such as the return of angina. Most returns of symptoms were already documented in the database before the formal follow-up and were based on the original documents of the attending cardiologists, documented a few days after the actual return. The additional cascade of letters further refined this information for the other patients. A follow-up studyGo 7 that used alternative follow-up methods (anniversary method) of patients with CABG with only venous grafts reported a similar freedom from angina as this study for patients with only venous grafts.

Limitations of the analytic method
A multivariable analysis comes closest to adjusting for the deliberate or unconscious patient selection in the variability of surgical techniques used. The complexity of the variables induce complex analyses, but they can generate patient-specific estimates useful for predictions. The strengths and limitations of these predictions on independent patient samplesGo 8 include: patients with new risks, variables unavailable for the analysis, variables with low numbers of patients at risk and therefore instability of the coefficients, and variables that have taken different meanings over time.

Deliberately imposed limitations
This study has been limited, by purpose, to the variables known before or at the time of surgery to permit prediction before the operation, even though the Katholieke Universiteit Leuven database contained time-related co-variables such as smoking habit and lipid values after the operation.

The impact of choice of procedure on the return of angina
The one completely controllable risk factor for the return of angina is the surgeon's choice of conduit for the operation. However, the benefit that can be anticipated in delaying the onset of angina by the use of extensive arterial grafting was found to be disappointingly small.

An earlier analysisGo 2 on a smaller data-set (n = 5880) with a shorter follow-up did not identify a beneficial effect on return of clinical ischemia of extensive arterial grafting over and above that afforded by a single arterial anastomosis. We speculatedGo 9 that, were the data-set larger and the follow-up longer, a progressive benefit of more extensive arterial grafting in reducing the early return of angina might be identified but that it was unlikely to reduce the clinically more important late return of angina.

Table V, a univariate and non-time–related presentation, suggests a benefit of the extensiveness of the arterial reconstruction, but this is before a correction for patient variability and method of use of this arterial grafting over time. Thus, in the present study with risk-adjustment, we found a progressive benefit on prevention of the early return of angina by more extensive arterial grafting, but the magnitude of this advantage was so small that the clinical benefit is trivial. Arterial grafting effected a small reduction in the late return of angina, but no incremental benefit of more extensive arterial grafting.


View this table:
[in this window]
[in a new window]
 
Table V. The univariate non-time–related comparison of the no. of events within the follow-up interval by no. of in situ thoracic artery distal anastomoses (P [{chi}2] = .001)
 
It remains possible for more extensive or complete arterial grafting to reduce very late clinical events (eg, 10 to 15 years after CABG), but a series of critical observations are appropriate. In our study, at 10 or 15 years after an operation only 61% and 38% of the surviving patients are at risk for the return of angina. With the mean age of the current CABG patient above 70 years at the time of surgery and his combination of co-morbidity, only a small segment of the current population could benefit from this possible residual hazard reduction. Also, because the late phase becomes dominant beyond 2 years after the operation, any substantial benefit of multiple arterial grafting should have become apparent. It did not, leading to the inference that the benefit must be small.

This disappointing finding follows on the heels of a similar disappointingGo 1 benefit of extensive arterial revascularization on early, late, and very late survival after CABG. Although that analysis identified neither increased nor decreased early risk with the use of either single or extensive thoracic artery grafting, it failed to identify reduced late risk by extensive arterial grafting. Even the benefit of single arterial in situ grafting was modest and vanished when severe comorbidity was present. This demonstrated that extensive data exploration is needed before statements can be made in situations where patient-mix can influence the results of operative strategy.

In addition to the choice of procedure, the other controllable factors are the surgeon and the environment. In our study, institutional variables identified as risk factors for the return of angina included the identification of 2 surgeons and variables describing their experience or their surgical protocols. These differences appeared only early. The magnitude of the differences at 1 month and 10 years after surgery between the 2 extremes of surgeons after normalization for patient and procedure variables are limited to 0.2% and 2%, respectively, and therefore not clinically important.

The impact of demography and comorbidity on the return of angina
The therapeutic environment of the patient with coronary disease is constantly changing. The patient-mix of the larger cardiac operation centers includes patients with impressive accumulations of cardiac and noncardiac co-morbidities. Immutable demography and co-morbidity were associated with the earlier return of angina. Improved cardiac drugs and interventional techniques are rightfully challenging coronary operations in parts of the coronary patient-spectrum and for some of the follow-up events. The optimization of medical decision making in patient-specific situationsGo 10 and for different follow-up events requires updates of the scientific bases and optimal correction for the patient variability.

In addition to the vascular co-morbidity variables (calcified aorta, vascular disease, and vascular surgery), expressing the extent of the atherosclerotic process, a large late impact was identified in the variables related to the initiation and progress of this atherosclerotic process (hypertension,Go 11 diabetic grade, renal failure, triglyceride value). Preoperative triglyceride values were already previously identified as incremental risk factors for several outcome events after CABG: survival,Go 1 return of angina,Go Go 2,12 first infarct,Go 2 any first ischemic event.Go 2 These variables demonstrate the progressive nature of the atherosclerotic process that cannot be expected to be stopped at the time of operation. Aggressive medical treatmentGo Go 13,14 and dietary regimens may interfere with these negative influences.

Clinical relevance of the return of angina after CABG for the patient
If the return of angina after a coronary operation is largely immutable, the choice of operative technique will delay its onset only mildly, and it is yet uncertain whether risk-factor intervention will be effective, it is fortunate that the return of angina appears to have limited consequence on survival. It is also only a modest predictor of impending infarct because only 3% of the patients will have an infarct the first month after the return of angina. The surgical or cardiologic reintervention rate after the return of angina was only 4% the first month, increasing within the first year to approximately 20%, then stabilizing after that interval. We have previously shown that survival after the return of angina is no different from that expected had angina not returned.Go 2 Whether a biologic or iatrogenic factor, reintervention is less common after the return of angina when multiple arterial grafting has been performed. The return of angina is therefore an event with possibly high emotional impact on the until-then symptom-free patient, but its clinical consequences seem limited.

Inferences relevant to minimally invasive direct coronary artery bypass surgery
Minimally invasive direct coronary artery bypass (MIDCAB) surgery results refer nearly always to aggregate results of groups of patients treated with more conventional CABG techniques. The extreme patient selection for these lesser invasive techniques requires more precise standards for comparison. A patient-specific prediction was made for the return of angina in a typical patient with a median-risk profile who has undergone MIDCAB; the prediction is further refined with minimal co-morbidity, stable angina, single vessel disease, and an ITA anastomosis to the LAD. The 1-month, 5-year, and 10-year freedom rate from angina for this typical patient who has undergone MIDCAB was 99.8%, 86%, and 59%, respectively. We believe this should be the standard of comparison for such procedures.

Clinical inferences
The study demonstrates that most patients, if they live long enough, will experience the return of angina, most frequently of a minor grade, within 15 to 20 years after their CABG. Thus the return of angina appears to be immutable after a coronary artery operation. Patients should not expect that use of multiple arterial grafts will lead to dramatic reduction in the occurrence of this event beyond the modest benefit afforded by a single arterial graft to the diseased LAD. Demographic variables are immutable, and coronary atherosclerosis is a chronic disease that has been in evolution in these patients for many years and has reached the level of hemodynamic and clinical significance. Coronary operations will not stop this process. However progression of disease can be delayed, theoretically, by the control of noncardiac comorbidity. Finally, the tendency, for whatever reasons, to avoid reintervention when arterial grafting is extensive appears to be prudent.


    Appendix: Discussion
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Appendix: Discussion
 Appendixes
 References
 
Dr. Bruce W. Lytle (Cleveland, Ohio). This is a follow-up of over 9000 patients undergoing operations for coronary bypass grafting, and it has a lot of strengths. The most important of these strengths is a 99.9% follow-up and a pattern of follow-up that is relatively continuous. These points are based on a very high degree of geographic localization of the patients involved and is a tribute to the tenacity of the investigators.

These data have been subjected to sophisticated and multi-directional statistical analyses. I am not going to ask any questions about Dr. Blackstone's methods because it is unlikely that I am capable of understanding the answers. But I do think that we need to examine the endpoint.

Most studies of bypass operations focus on death and reoperation, because these events are not subjective and they have obvious clinical importance. My understanding is that first return of angina was a clinical diagnosis made by a referring cardiologist. Not only was it a subjective diagnosis, but the angina that occurred could have been an isolated event followed by a relatively benign clinical course. Do you have any data or any feelings about the data about the importance of a first-return-of-angina event in terms of predicting subsequent bad outcomes for the patient, death, reoperation, or disabling angina?

A second line of inquiry has to do with the business about arterial grafting. It does not appear that the strategy of complex arterial grafting had a major impact on the late return of angina, or whatever this event is. Now, we do need to realize that despite the 20-year extent of the study, the median follow-up was about 6 years, and only 128 patients with more than 1 internal thoracic artery anastomosis were followed for more than 10 years. So in reference to complex arterial grafting, this is really a study of the first decade after bypass operation.

I think the sensitivity of the event also has to be considered, because any time there are events that are extremely sensitive, they tend to blur the distinction among methods of treatment.

Furthermore, I would bet there was a very close covariance between young age, which is a very strong predictor of the recurrence of angina, and complex arterial grafting. Do you think you are able to perfectly isolate the effect of those very closely related variables even with multivariate techniques?

What implications do you think this study has in terms of your own practice in regard to the strategies of complex arterial grafting?

Lastly, interpreting the overall results, we can take solace from the sensitive nature of this endpoint. The fact that at the end of 20 years over 20% of the surviving patients had not had even a single event that some cardiologists might think was angina is, I think, remarkable.

Dr. Sergeant. First return of angina, is it a good outcome marker? First return of angina is a very sensitive marker. One day of angina, as you have pointed out, will have the event-flag go down and stay down forever.

This event was identified by the attending cardiologists or by the 2 senior researchers involved and mentioned as authors. A lot of effort was invested in the identification and refinement of the actual first return of angina.

Is it an important marker? We think it is an important marker. Even though it is sensitive, it is an important marker because it is the prime marker on the quality of life after coronary bypass operation. The uncertainty for the patient of the first return of angina is very destabilizing.

Is it an important marker for the late outcome? This is beyond the scope of this actual presentation, but we have explored this domain already in a previous analysis of the same event for a smaller dataset. This exploration indicated that the patients with return of angina, without infarct or death the same day, have a similar survival rate to the patients without this event.

There are 2 possible explanations: either the first return of angina is not a good outcome marker, or we have been treating these patients perfectly, no overtreatment nor undertreatment. I would doubt this last possibility very much. I would therefore propose that it does not seem to be a good outcome marker.

Dr. Lytle is referring to Table I in the article when he mentions arterial grafting and the extent of follow-up, and it has to be noted that this is just a listing of each individual use of arterial grafts. Please note that the late-hazard phase starts to rise by 2 years. At 5 years in follow-up, there are 2269 patients with a single thoracic artery, and there are 609 patients with a double thoracic artery. These are only the in situ thoracic artery reconstructions; free and other arterial grafts need to be added to get a complete overview of extensive arterial grafting in this dataset.

The median follow-up duration is very much related to the entry of patients into the study. A completely uniform entry of patients over 20 years would optimize this median follow-up to 10 years maximum. The only possible inference of the median follow-up is that it reflects nonuniform entry of patients and the growth of our cardiac surgical program.

Younger age very strongly influences the return of angina. But as you have seen on the depictions, younger age does not interact significantly with arterial grafting. Extensive analysis was done into this relationship, and no additional interaction could be identified.

In the presentation in PragueGo 1 (EACTS 96), the benefit of extensive arterial grafting on survival was studied. There was no overwhelming benefit, even of the use of a single thoracic artery, and absolutely no benefit (once the patient variables were completely corrected for) in extending the use of arterial grafting.

We are therefore at this moment in time still using more extensive arterial revascularization but not going toward the extreme. The possible benefit on any event of radial and gastroepiploic artery grafting seems very distant if not unreachable, if the second thoracic artery benefit is so parsimonious. If there is no contraindication for the second thoracic artery, there seems to be no reason not to use it.


    Appendixes
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Appendix: Discussion
 Appendixes
 References
 
Appendix 1. Estimates for final model parameters (patient, procedure, and institutional variables):

Early phase: d = 0; r = 1.053; n = 0; M  = 1
Late phase: t = 1; g = 2.089; a = 1; h = 1

Appendix 2. The selected variables, their coefficients, their standard error and their mathematic transformations for the final model (patient, procedure, and institutional variables):

Early phase: intercept = –3.980

Younger age ([age (years)/50]2,squared transformation) = –0.5386 ± 0.122; female gender = 0.7586 ± 0.103; longer duration of angina history (ln[duration (months) natural logarithmic transformation] = 0.1524 ± 0.033; unstable ST-segment at surgery = 0.5267 ± 0.086; clinically positive exercise test = 0.3942 ± 0.166, and electrocardiogram negative exercise test  = 9.5794 ± 9.180 (subgroup of patients experiencing onset of angina during exercise testing before electrocardiographic changes are evident); greater stenosis of left main coronary artery ([% stenosis/100]2, squared transformation) = –9.8522 ± 9.27; history of peripheral vascular disease = 0.6062 ± 0.116; use of vein grafts only = –0.5739 ± 0.24; use of patch grafts = 0.1.325 ± 0.28; proportion of total distal anastomoses to vessels of size 1 mm or less = 0.6602 ± 0.2; grafting to the LAD system = –0.3436 ± 0.133; lower ratio of the number of arterial anastomoses to total number of distal anastomoses (1/[ratio + 0.5] inverse transformation) = 0.9393 ± 0.26; incomplete revascularisation = 0.4976 ± 0.108 and use of internal thoracic grafts only = 0.74 ± 0.3 (subset of patients who were incompletely revascularized, and only internal thoracic arterial grafts were used); number of coronary endarterectomies = 0.4937 ± 0.14; high risk for angina return surgeon = 0.3485 ± 0.106; low risk for angina return surgeon = –0.3052 ± 0.113

Late phase: intercept = –6.550

Younger age (ln (years) logarithmic transformation) = –0.9071 ± 0.2; female gender = 0.3304 ± 0.072; longer duration of angina history (ln[duration (months) natural logarithmic transformation] = 0.3304 ± 0.072; higher angina class (ln[(angina class) + 1] natural logarithmic transformation) = 0.3414 ± 0.062; preoperative anterior or septal infarct = –0.2570 ± 0.102; greater stenosis of left main coronary artery ([% stenosis/100] scaling transformation) = –0.2364 ± 0.099; multi-system coronary artery disease (2 or more systems diseased by 70% diameter reduction criterion) = 0.2291 ± 0.083; mild aortic valve stenosis = 0.4595 ± 0.2; left ventricular hypertrophy (by electrocardiographic criteria) = 0.2144 ± 0.085; history of non-carotid vascular surgery = 0.5204 ± 0.155; calcified ascending aorta = 0.7202 ± 0.3; overweight now or previously (more than 10 kg over ideal weight: for male patients, ideal weight is [height (cm)-100], and for female patients, ideal weight is [height (cm)-110]) = –0.8918 ± 0.34 and older age (product of age [years] and obesity indicator variable [interaction term])= 0.01818 ± 0.0062; hypertensive (defined as a systolic blood pressure greater than 160 mm Hg, a diastolic blood pressure greater than 100 mm Hg, or being medicated for hypertension by history) = 0.01748 ± 0.052; higher diabetic grade (grade 0, no diabetes; grade 1, abnormal glucose tolerance test with dietary treatment; grade 2, diabetic, receiving oral hypoglycemic treatment; grade 3, insulin-treated diabetes. The squared transform of diabetic grade is used.) = 0.05179 ± 0.0146; higher preoperative triglyceride level (ln[triglyceride level(mg/dl)] logarithmic transformation) = 0.1818 ± 0.054; history of renal failure (patients receiving dialysis therapy or having received renal transplantation) = 1.218 ± 0.31; use of vein grafts to the LAD system = 0.1517 ± 0.051; later date of operation ([date/13]2 squared, scaled transformation of date of operation expressed as the number of years between January 1, 1971, and the calendar date of the operation) = 0.3458 ± 0.067


    Acknowledgments
 
We thank all cardiologists (national or international) who have voluntary submitted more then 50,000 original medical documents, in particular the colleagues from the University Hospitals, Katholieke Universiteit Leuven (chairmen, H. De Geest and F. Van De Werf).


    References
 Top
 Abstract
 Introduction
 Methods
 Results
 Discussion
 Appendix: Discussion
 Appendixes
 References
 

  1. Sergeant PT, Blackstone EH, Meyns B, the K.U. Leuven Coronary Surgery Program. Identification, validation and interdependence with patient-variables of the influence of procedural variables on early and late survival after CABG. Eur J  Cardiothorac Surg 1997;12:1-19.[Abstract]
  2. Sergeant PT, Lesaffre E, Flameng W, Suy R, Blackstone EH. The return of clinically evident ischemia after coronary artery bypass grafting. Eur J Cardiothorac Surg 1991;5:447-57.[Abstract]
  3. Sergeant PT, Flameng W, Suy R. The mammary artery jumpgraft. Eur J Cardiothorac Surg 1988;29:596-600.
  4. Sergeant PT, Lesaffre E. The K.U. Leuven Coronary Surgery Data Base, a clinical research data base. In: Meester GT, Pinciroli F, editors. Databases for cardiology. Amsterdam: Kluwer Academic; 1990. p.223-37.
  5. Kaplan E, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
  6. van Brussel B, Plokker HW, Ernst SM, Ernst NM, Knaepen PJ, Koomen EM, et al. Venous coronary artery surgery: a 15-year follow-up study. Circulation 1993;88(part 2):87-92.
  7. Blackstone EH, Naftel D, Turner M. The decomposition of time-varying hazards into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81:615-24.
  8. Sergeant P, Blackstone E, Meyns B, the K.U. Leuven Coronary Surgery Program. Can the outcome of coronary bypass grafting be predicted reliably? Eur J Cardiothorac Surg 1997;11:2-9.[Abstract]
  9. Sergeant P. Risks and prediction of adverse events after coronary bypass grafting based on a single center experience. In: L|$$|Aduscher TF, Turina M, Braunwald E, editors. Coronary artery graft disease, mechanisms and prevention. Berlin: Springer Verlag; 1994. p.16-41.
  10. Kirklin JW, Barratt-Boyes B. Patient-specific predictions and comparisons in ischemic heart disease. In: Cardiac surgery. New York: Churchill Livingstone; 1993. p.344-68.
  11. Risum O, Abdelnoor M, Svennevig JL, Levorstad K, Nitter-Hauge S. Risk factors of recurrent angina pectoris and non-fatal myocardial infarction after coronary artery bypass surgery. Eur J  Cardiothorac Surg 1996;10:173-8.[Abstract]
  12. van Brussel B, Plokker HW, Ernst SM, Ernst NM, Knaepen PJ, Koomen EM, et al. Multivariate risk factor analysis of clinical outcome 15 years after venous coronary artery bypass graft surgery. Eur Heart J 1995;16:1200-6.[Abstract/Free Full Text]
  13. Inserra F, Romano L, Ercole L, de Cavanagh EM, Ferder L. Cardiovascular changes by long-term inhibition of the renin-angiotensin system in aging. Hypertension 1995;25:437-42.[Abstract/Free Full Text]
  14. Clozel JP, Hess P, Michael C, Schietinger K, Baumgartner HR. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs. Hypertension 1991;18:II55-9.



This article has been cited by other articles:


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Akujuo, G. W. Fischer, and J. Chikwe
Current Concepts in Reoperative Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2009; 13(4): 206 - 214.
[Abstract] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Subramanian, J. F. Sabik III, P. L. Houghtaling, E. R. Nowicki, E. H. Blackstone, and B. W. Lytle
Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending.
Ann. Thorac. Surg., May 1, 2009; 87(5): 1392 - 1398.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
E. Gongora and T. M. Sundt III
Myocardial Revascularization with Cardiopulmonary Bypass
Card. Surg. Adult, January 1, 2008; 3(2008): 599 - 632.
[Full Text]


Home page
CirculationHome page
J. F. Sabik III, E. H. Blackstone, A. M. Gillinov, N. G. Smedira, and B. W. Lytle
Occurrence and Risk Factors for Reintervention After Coronary Artery Bypass Grafting
Circulation, July 4, 2006; 114(1_suppl): I-454 - I-460.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Sirivella, I. Gielchinsky, and V. Parsonnet
Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease
Ann. Thorac. Surg., November 1, 2005; 80(5): 1738 - 1744.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. G. Byrne, A. N. Karavas, T. Gudbjartson, M. Leacche, J. D. Rawn, G. S. Couper, R. J. Rizzo, L. H. Cohn, and S. F. Aranki
Left anterior descending coronary endarterectomy: Early and late results in 196 consecutive patients
Ann. Thorac. Surg., September 1, 2004; 78(3): 867 - 873.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
U. N. Khot, D. T. Friedman, G. Pettersson, N. G. Smedira, J. Li, and S. G. Ellis
Radial Artery Bypass Grafts Have an Increased Occurrence of Angiographically Severe Stenosis and Occlusion Compared With Left Internal Mammary Arteries and Saphenous Vein Grafts
Circulation, May 4, 2004; 109(17): 2086 - 2091.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Steuer, P. Blomqvist, F. Granath, B. Rydh, A. Ekbom, U. de Faire, and E. Stahle
Hospital readmission after coronary artery bypass grafting: are women doing worse?
Ann. Thorac. Surg., May 1, 2002; 73(5): 1380 - 1386.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Berreklouw, P. P.C. Rademakers, J. M. Koster, L. van Leur, B. J.W. van der Wielen, and P. Westers
Better ischemic event-free survival after two internal thoracic artery grafts: 13 years of follow-up
Ann. Thorac. Surg., November 1, 2001; 72(5): 1535 - 1541.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Matsa, Y. Paz, J. Gurevitch, I. Shapira, A. Kramer, D. Pevny, and R. Mohr
Bilateral skeletonized internal thoracic artery grafts in patients with diabetes mellitus
J. Thorac. Cardiovasc. Surg., April 1, 2001; 121(4): 668 - 674.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. Noyez
The ITA pedicle: a ""protecting cloak"" for the graft of choice
Ann. Thorac. Surg., September 1, 2000; 70(3): 1005 - 1005.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Scott, E. H. Blackstone, P. M. McCarthy, B. W. Lytle, F. D. Loop, J. A. White, and D. M. Cosgrove
Isolated bypass grafting of the left internal thoracic artery to the left anterior descending coronary arteryLate consequences of incomplete revascularization
J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 173 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. H. Blackstone and B. W. Lytle
COMPETING RISKS AFTER CORONARY BYPASS SURGERY: THE INFLUENCE OF DEATH ON REINTERVENTION
J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1221 - 1232.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. M. Sundt III, C. J. Camillo, E. N. Mendeloff, H. B. Barner, and W. A. Gay Jr
Reappraisal of coronary endarterectomy for the treatment of diffuse coronary artery disease
Ann. Thorac. Surg., October 1, 1999; 68(4): 1272 - 1277.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
P. T. Sergeant and E. H. Blackstone
Closing the loop: optimizing physicians’ operational and strategic behavior
Ann. Thorac. Surg., August 1, 1999; 68(2): 362 - 366.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. M. Sundt III, H. B. Barner, C. J. Camillo, and W. A. Gay Jr
Total arterial revascularization with an internal thoracic artery and radial artery T graft
Ann. Thorac. Surg., August 1, 1999; 68(2): 399 - 404.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. D. Loop
Coronary artery surgery: the end of the beginning
Eur. J. Cardiothorac. Surg., December 1, 1998; 14(6): 554 - 571.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sergeant, P.
Right arrow Articles by Meyns, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sergeant, P.
Right arrow Articles by Meyns, B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS